Wei Zhuang - Research Center of Carcinogenesis and Targeted Therapy, Central South University

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 53 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prediction Accuracy of Biomarkers for Response to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Wei Zhuang,Jie Zhao,Boyang Sun,Hua Bai,Zhijie Wang,Jia Zhong,Rui Wan,Lihui Liu,Jianchun Duan,Jie Wang

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0引用

Decision Model for Durable Clinical Benefit from Front- or Late-Line Immunotherapy Alone or with Chemotherapy in Large Population of Non-Small Cell Lung Cancer

Jie Zhao,Lu Wang, Shidi Wen,Anda Zhou,Wenfeng Fang,Li Zhang,Jianchun Duan,Hua Bai,Jia Zhong,Rui Wan,Boyang Sun,Wei Zhuang, Yi‐Wen Lin, Dao‐Yao He,Zhijie Wang,Jie Wang

Journal of Clinical Oncologyno. 16_suppl (2024): e20533-e20533

引用0浏览0引用

Evaluation of First-Line and Salvage Therapies for Unresectable Malignant Mesothelioma: A Systematic Review and Network Meta-Analysis

Wei Zhuang,Lihui Liu,Boyang Sun,Hua Bai,Zhijie Wang,Jianchun Duan,Rui Wan,Zixiao Ma,Jia Zhong,Jie Wang

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

引用0浏览0WOS引用

Decision Model for Durable Clinical Benefit from Front- or Late-Line Immunotherapy Alone or with Chemotherapy in Non-Small Cell Lung Cancer

Jie Zhao,Lu Wang, Shidi Wen,Anda Zhou,Wenfeng Fang,Li Zhang,Jianchun Duan,Hua Bai,Jia Zhong,Rui Wan,Boyang Sun,Wei Zhuang,Yiwen Lin, Danming He,Zhijie Wang,Jie Wang

Med（2024）

引用0浏览0WOS引用

Toripalimab Plus Chemotherapy for First Line Treatment of Advanced Non-Small Cell Lung Cancer (Choice-01): Final Os and Biomarker Exploration of a Randomized, Double-Blind, Phase 3 Trial

SIGNAL TRANSDUCTION AND TARGETED THERAPYno. 1 (2024)

引用0浏览0WOSNATURE引用

NPAS2 Dampens Chemo-Sensitivity of Lung Adenocarcinoma Cells by Enhancing DNA Damage Repair

Youyu Zhang,Yuqiao Chen,Wentao Huang,Yuan Zhou,Ya Wang,Kai Fu,Wei Zhuang

CELL DEATH & DISEASEno. 1 (2024)

引用1浏览0WOSNATURE引用

Prediction Performance Comparison of Biomarkers for Response to Immune Checkpoint Inhibitors in Advanced Non‐small Cell Lung Cancer

Jie Zhao,Wei Zhuang,Boyang Sun,Hua Bai,Zhijie Wang,Jia Zhong,Rui Wan,Lihui Liu,Jianchun Duan,Jie Wang

Thoracic cancerno. 13 (2024): 1050-1059

引用0浏览0WOS引用

A Lung Adenocarcinoma with Rare Epidermal Growth Factor Receptor Exon 20 V774M Mutation Was Sensitive to Osimertinib: A Case Report and Molecular Structural Analysis

Wei Zhuang,Jia Zhong,Jie Wang

Lung Cancer（2023）

引用0浏览0WOS引用

Long Non-Coding RNAs in Non-Small Cell Lung Cancer: Implications for EGFR-TKI Resistance

Detian Liu,Xiaolin Lu,Wentao Huang,Wei Zhuang

Frontiers in genetics (2023): 1222059-1222059

引用0浏览0WOS引用

ANXA1-derived Peptide for Targeting PD-L1 Degradation Inhibits Tumor Immune Evasion in Multiple Cancers

Zheng-Zheng Yu,Yun-Ya Liu,Wei Zhu,Ding Xiao,Wei Huang,Shan-Shan Lu,Hong Yi,Ting Zeng,Xue-Ping Feng,Li Yuan,Jie-Ya Qiu,Di Wu, Qi Wen,Jian-Hua Zhou,Wei Zhuang,Zhi-Qiang Xiao

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 3 (2023)

引用20浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn